CEO Update - 29 August 2023

I return from holiday to the news that Abcam, a key British life science company founded in 1998, is to be acquired by Danaher, bringing to a conclusion a headline-grabbing intervention this year by founder Jonathan Milner. Once again, this shows the global attractiveness of a global life science company built in the UK. Jonathan already has a track record for supporting the next-generation UK life science businesses and I hope he will continue to do so with some of the new proceeds from the sale.

10 drugs to face Medicare price negotiations 

The US today selected the first 10 drugs subject to Medicare price negotiations an important step in the development of the new legislation under the Inflation Reduction Act (IRA). If you need a refresher on why this matters for life science companies, take a look at the "IRA: Threats and opportunities for UK life sciences" webinar recording. This will remain a moving story, especially as there is a significant judicial challenge to the act in the US Court.

BIA Board Nomincations open

We are delighted to invite nominations from individuals interested in joining our BIA Board. Nominations for next year's board must be received by Friday, 15 September. This year, there are five places up for election for the corporate members and one for other members. If you’re interested in applying please contact company secretary, Nick Gardiner.

Steve Bates Headshot.png



Steve Bates OBE
CEO, BioIndustry Association

More news and updates

SiSaf’s bio-courier technology enables clinical trial success for topical treatment of mild to moderate Alopecia areata

SiSaf Ltd announced that a licensee of the ProSilic® variant of its technology has reported positive topline results from a randomised, placebo-controlled, multi-dose Phase II trial evaluating its topical treatment for mild to moderate (patchy) alopecia areata.

Manchester Met opens applications for September cohort of degree apprenticeships in science and sustainability

Employers looking for new talent or to upskill their current workforce can benefit from degree apprenticeships, starting Autumn 2024.

Discovery Park partners with Canterbury Christ Church University to open CoLab

Discovery Park, Kent’s thriving life science community, has opened the doors to CoLab, a new shared lab facility. In partnership with Canterbury Christ Church University, CoLab has been specially designed for early-stage life science businesses, providing flexible bench space in a collaborative coworking environment.

New blood test could prevent sudden child deaths caused by hereditary heart condition

A new blood test that could identify children with a potentially fatal heart condition has been developed by researchers at UCL (University College London) and Great Ormond Street Hospital (GOSH), thanks to investment from the charity Action Medical Research and self-funded not-for-profit, LifeArc.

CEO Update - 10 June 2024

UK General Election and what it might mean for the industry, including Labour's pledges on Brexit and business taxes. Upcoming events including the Cambridge Wide Open Day and the Life Science Leadership Summit. UK tech companies pitching at the London Stock Exchange and Amber Therapeutics securing $100 million in funding.

Macomics announces appointment of Simon Dew as new Chief Business Officer

Macomics Ltd, a leader in macrophage drug discovery has announced the appointment of Simon Dew in the newly created position of Chief Business Officer (CBO). He will be instrumental in advancing Macomics’ mission to develop first-in-class medicines targeting macrophage-driven diseases of high unmet medical need, in oncology and chronic inflammatory diseases.

More within